Oral exposure to Trypanosoma cruzi elicits a systemic CD8+ T cell response and protection against heterotopic challenge

Infection and Immunity

Volumn 79, Issue 8, 2011, Pages 3397-3406

  Collins, Matthew H ^a   Craft, Julie M ^a   Bustamante, Juan M ^a   Tarleton, Rick L ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIVE VACCINE; TRYPANOSOMA CRUZI VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHAGAS DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; MOUSE; MOUTH INFECTION; MUSCLE TISSUE; NONHUMAN; PRIORITY JOURNAL; TRYPANOSOMA CRUZI; VACCINATION; WILD TYPE;

ADMINISTRATION, ORAL; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CHAGAS DISEASE; CROSS PROTECTION; MICE; MICE, INBRED C57BL; MUSCLES; PROTOZOAN VACCINES; TRYPANOSOMA CRUZI; VACCINES, ATTENUATED;

EID: 79961101342     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01080-10     Document Type: Article

References (68)

1. Amino, R., et al. 2006. Quantitative imaging of Plasmodium transmission from mosquito to mammal. Nat. Med. 12:220-224.
2. Atwood, J. A., III, et al. 2005. The Trypanosoma cruzi proteome. Science 309:473-476.
3. Bell, L. V., and K. J. Else. 2008. Mechanisms of leucocyte recruitment to the inflamed large intestine: redundancy in integrin and addressin usage. Parasite Immunol. 30:163-170.
4. Belyakov, I. M., and J. D. Ahlers. 2009. Comment on "trafficking of antigenspecific CD8+ T lymphocytes to mucosal surfaces following intramuscular vaccination." J. Immunol. 182:1779-1780.
5. Belyakov, I. M., et al. 1998. The importance of local mucosal HIV-specific CD8(+) cytotoxic T lymphocytes for resistance to mucosal viral transmission in mice and enhancement of resistance by local administration of IL-12. J. Clin. Invest. 102:2072-2081.
6. Bourguignon, S. C., W. de Souza, and T. Souto-Padron. 1998. Localization of lectin-binding sites on the surface of Trypanosoma cruzi grown in chemically defined conditions. Histochem. Cell Biol. 110:527-534.
7. Bustamante, J. M., L. M. Bixby, and R. L. Tarleton. 2008. Drug-induced cure drives conversion to a stable and protective CD8+ T central memory response in chronic Chagas disease. Nat. Med. 14:542-550.
8. Calzascia, T., et al. 2005. Homing phenotypes of tumor-specific CD8 T cells are predetermined at the tumor site by crosspresenting APCs. Immunity 22:175-184.
9. Canavaci, A. M., et al. 2010. In vitro and in vivo high-throughput assays for the testing of anti-Trypanosoma cruzi compounds. PLoS Negl. Trop. Dis. 4:e740.
10. Cazorla, S. I., et al. 2008. Oral vaccination with Salmonella enterica as a cruzipain-DNA delivery system confers protective immunity against Trypanosoma cruzi. Infect. Immun. 76:324-333.
11. Cazorla, S. I., et al. 2008. Prime-boost immunization with cruzipain coadministered with MALP-2 triggers a protective immune response able to decrease parasite burden and tissue injury in an experimental Trypanosoma cruzi infection model. Vaccine 26:1999-2009.
12. Chakravarty, S., et al. 2007. CD8+ T lymphocytes protective against malaria liver stages are primed in skin-draining lymph nodes. Nat. Med. 13:1035-1041.
13. Cohen, J. E., and R. E. Gurtler. 2001. Modeling household transmission of American trypanosomiasis. Science 293:694-698.
14. Coura, J. R., A. C. Junqueira, O. Fernandes, S. A. Valente, and M. A. Miles. 2002. Emerging Chagas disease in Amazonian Brazil. Trends Parasitol. 18: 171-176.
15. Courret, N., et al. 2006. CD11c- and CD11b-expressing mouse leukocytes transport single Toxoplasma gondii tachyzoites to the brain. Blood 107:309-316.
16. Cummings, K. L., and R. L. Tarleton. 2003. Rapid quantitation of Trypanosoma cruzi in host tissue by real-time PCR. Mol. Biochem. Parasitol. 129: 53-59.
17. Dias, J. C., A. C. Silveira, and C. J. Schofield. 2002. The impact of Chagas disease control in Latin America: a review. Mem. Inst. Oswaldo Cruz 97: 603-612.
18. Dudda, J. C., et al. 2005. Dendritic cells govern induction and reprogramming of polarized tissue-selective homing receptor patterns of T cells: important roles for soluble factors and tissue microenvironments. Eur. J. Immunol. 35:1056-1065.
19. El-Asady, R., et al. 2005. TGF-{beta}-dependent CD103 expression by CD8(+) T cells promotes selective destruction of the host intestinal epithelium during graft-versus-host disease. J. Exp. Med. 201:1647-1657.
20. Estrada-Franco, J. G., et al. 2006. Human Trypanosoma cruzi infection and seropositivity in dogs, Mexico. Emerg. Infect. Dis. 12:624-630.
21. Giddings, O. K., C. S. Eickhoff, T. J. Smith, L. A. Bryant, and D. F. Hoft. 2006. Anatomical route of invasion and protective mucosal immunity in Trypanosoma cruzi conjunctival infection. Infect. Immun. 74:5549-5560.
22. Gürtler, R. E., et al. 2007. Domestic dogs and cats as sources of Trypanosoma cruzi infection in rural northwestern Argentina. Parasitology 134:69-82.
23. Hoft, D. F., and C. S. Eickhoff. 2005. Type 1 immunity provides both optimal mucosal and systemic protection against a mucosally invasive, intracellular pathogen. Infect. Immun. 73:4934-4940.
24. Hoft, D. F., and C. S. Eickhoff. 2002. Type 1 immunity provides optimal protection against both mucosal and systemic Trypanosoma cruzi challenges. Infect. Immun. 70:6715-6725.
25. Hoft, D. F., C. S. Eickhoff, O. K. Giddings, J. R. Vasconcelos, and M. M. Rodrigues. 2007. Trans-sialidase recombinant protein mixed with CpG motif-containing oligodeoxynucleotide induces protective mucosal and systemic trypanosoma cruzi immunity involving CD8+ CTL and B cell-mediated cross-priming. J. Immunol. 179:6889-6900.
26. Hoft, D. F., P. L. Farrar, K. Kratz-Owens, and D. Shaffer. 1996. Gastric invasion by Trypanosoma cruzi and induction of protective mucosal immune responses. Infect. Immun. 64:3800-3810.
27. Holmgren, J., and C. Czerkinsky. 2005. Mucosal immunity and vaccines. Nat. Med. 11:S45-S53.
28. Igreja, R. P. 2009. Chagas disease 100 years after its discovery. Lancet 373:1340.
29. Jiang, J. Q., X. S. He, N. Feng, and H. B. Greenberg. 2008. Qualitative and quantitative characteristics of rotavirus-specific CD8 T cells vary depending on the route of infection. J. Virol. 82:6812-6819.
30. Johansson-Lindbom, B., and W. W. Agace. 2007. Generation of gut-homing T cells and their localization to the small intestinal mucosa. Immunol. Rev. 215:226-242.
31. Kaufman, D. R., et al. 2008. Trafficking of antigen-specific CD8+ T lymphocytes to mucosal surfaces following intramuscular vaccination. J. Immunol. 181:4188-4198.
32. Klonowski, K. D., et al. 2004. Dynamics of blood-borne CD8 memory T cell migration in vivo. Immunity 20:551-562.
33. Laky, K., L. Lefrancois, and L. Puddington. 1997. Age-dependent intestinal lymphoproliferative disorder due to stem cell factor receptor deficiency: parameters in small and large intestine. J. Immunol. 158:1417-1427.
34. Martin, D., and R. Tarleton. 2004. Generation, specificity, and function of CD8+ T cells in Trypanosoma cruzi infection. Immunol. Rev. 201: 304-317.
35. Martin, D. L., et al. 2006. CD8+ T-cell responses to Trypanosoma cruzi are highly focused on strain-variant trans-sialidase epitopes. PLoS Pathog. 2:e77.
36. Masopust, D., et al. 2010. Dynamic T cell migration program provides resident memory within intestinal epithelium. J. Exp. Med. 207:553-564.
37. Masopust, D., J. Jiang, H. Shen, and L. Lefrancois. 2001. Direct analysis of the dynamics of the intestinal mucosa CD8 T cell response to systemic virus infection. J. Immunol. 166:2348-2356.
38. Masopust, D., V. Vezys, A. L. Marzo, and L. Lefrancois. 2001. Preferential localization of effector memory cells in nonlymphoid tissue. Science 291: 2413-2417.
39. Mathers, C. D., M. Ezzati, and A. D. Lopez. 2007. Measuring the burden of neglected tropical diseases: the global burden of disease framework. PLoS Negl. Trop. Dis. 1:e114.
40. Meeusen, E. N., J. Walker, A. Peters, P. P. Pastoret, and G. Jungersen. 2007. Current status of veterinary vaccines. Clin. Microbiol. Rev. 20:489-510.
41. Mestecky, J., M. W. Russell, and C. O. Elson. 2007. Perspectives on mucosal vaccines: is mucosal tolerance a barrier? J. Immunol. 179:5633-5638.
42. Miyahira, Y. 2008. Trypanosoma cruzi infection from the view of CD8+ T cell immunity: an infection model for developing T cell vaccine. Parasitol. Int. 57:38-48.
43. Miyahira, Y., et al. 1999. Induction of CD8+ T cell-mediated protective immunity against Trypanosoma cruzi. Int. Immunol. 11:133-141.
44. Miyahira, Y., et al. 2005. Immune responses against a single CD8+-T-cell epitope induced by virus vector vaccination can successfully control Trypanosoma cruzi infection. Infect. Immun. 73:7356-7365.
45. Mora, J. R., et al. 2005. Reciprocal and dynamic control of CD8 T cell homing by dendritic cells from skin- and gut-associated lymphoid tissues. J. Exp. Med. 201:303-316.
46. Neutra, M. R., and P. A. Kozlowski. 2006. Mucosal vaccines: the promise and the challenge. Nat. Rev. Immunol. 6:148-158.
47. Offit, P. A., S. L. Cunningham, and K. I. Dudzik. 1991. Memory and distribution of virus-specific cytotoxic T lymphocytes (CTLs) and CTL precursors after rotavirus infection. J. Virol. 65:1318-1324.
48. Padilla, A. M., L. J. Simpson, and R. L. Tarleton. 2009. Insufficient TLR activation contributes to the slow development of CD8+ T cell responses in Trypanosoma cruzi infection. J. Immunol. 183:1245-1252.
49. Peters, N. C., et al. 2008. In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies. Science 321:970-974.
50. Rabinovich, J., N. Schweigmann, V. Yohai, and C. Wisnivesky-Colli. 2001. Probability of Trypanosoma cruzi transmission by Triatoma infestans (Hemiptera: Reduviidae) to the opossum Didelphis albiventris (Marsupialia: Didelphidae). Am. J. Trop. Med. Hyg. 65:125-130.
51. Reithinger, R., L. Ceballos, R. Stariolo, C. R. Davies, and R. E. Gurtler. 2005. Chagas disease control: deltamethrin-treated collars reduce Triatoma infestans feeding success on dogs. Trans. R. Soc. Trop. Med. Hyg. 99:502-508.
52. Reithinger, R., R. L. Tarleton, J. A. Urbina, U. Kitron, and R. E. Gurtler. 2009. Eliminating Chagas disease: challenges and a roadmap. BMJ 338: b1283.
53. Rivera-Nieves, J., et al. 2005. L-Selectin, alpha 4 beta 1, and alpha 4 beta 7 integrins participate in CD4+ T cell recruitment to chronically inflamed small intestine. J. Immunol. 174:2343-2352.
54. Rodrigues, M. M., et al. 2003. Importance of CD8 T cell-mediated immune response during intracellular parasitic infections and its implications for the development of effective vaccines. An. Acad. Bras. Cienc. 75:443-468.
55. Roellig, D. M., A. E. Ellis, and M. J. Yabsley. 2009. Oral transmission of Trypanosoma cruzi with opposing evidence for the theory of carnivory. J. Parasitol. 95:360-364.
56. Round, J. L., and S. K. Mazmanian. 2009. The gut microbiota shapes intestinal immune responses during health and disease. Nat. Rev. Immunol. 9:313-323.
57. Schnapp, A. R., C. S. Eickhoff, J. Scharfstein, and D. F. Hoft. 2002. Induction of B- and T-cell responses to cruzipain in the murine model of Trypanosoma cruzi infection. Microbes Infect. 4:805-813.
58. Schnapp, A. R., C. S. Eickhoff, D. Sizemore, R. Curtiss III, and D. F. Hoft. 2002. Cruzipain induces both mucosal and systemic protection against Trypanosoma cruzi in mice. Infect. Immun. 70:5065-5074.
59. Schön, M. P., et al. 1999. Mucosal T lymphocyte numbers are selectively reduced in integrin alpha E (CD103)-deficient mice. J. Immunol. 162:6641-6649.
60. Shiow, L. R., et al. 2006. CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature 440:540-544.
61. Stuart, K., et al. 2008. Kinetoplastids: related protozoan pathogens, different diseases. J. Clin. Invest. 118:1301-1310.
62. Tarleton, R. L. 1990. Depletion of CD8+ T cells increases susceptibility and reverses vaccine-induced immunity in mice infected with Trypanosoma cruzi. J. Immunol. 144:717-724.
63. Tarleton, R. L. 2005. New approaches in vaccine development for parasitic infections. Cell. Microbiol. 7:1379-1386.
64. Winnard, P. T., Jr., J. B. Kluth, and V. Raman. 2006. Noninvasive optical tracking of red fluorescent protein-expressing cancer cells in a model of metastatic breast cancer. Neoplasia 8:796-806.
65. Wizel, B., N. Garg, and R. L. Tarleton. 1998. Vaccination with trypomastigote surface antigen 1-encoding plasmid DNA confers protection against lethal Trypanosoma cruzi infection. Infect. Immun. 66:5073-5081.
66. Xu, D., C. P. Brandan, M. A. Basombrio, and R. L. Tarleton. 2009. Evaluation of high efficiency gene knockout strategies for Trypanosoma cruzi. BMC Microbiol. 9:90.
67. Yoshida, N. 2008. Trypanosoma cruzi infection by oral route: how the interplay between parasite and host components modulates infectivity. Parasitol. Int. 57:105-109.
68. Zhang, L., and R. L. Tarleton. 1999. Parasite persistence correlates with disease severity and localization in chronic Chagas' disease. J. Infect. Dis. 180:480-486.